Biodesix, Inc. BDSX

Full chart Compare
Set alert

Price alert · BDSX

All alert types
21.49 USD +0.44 (+2.09%)

At closeNov 4, 2026, 4:00 PM EST

21.49 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

20.46 Day range 22.23
5.26 52-week range 31.97
YTD
+216.03%
1 year
+182.76%

Revenue & Expenses

Revenue by
Diagnostic Tests → Revenue: $79.20MRevenue → Gross Profit: $71.78MGross Profit → Expenses: $71.78MRevenue → Cost of Revenue: $16.72MExpenses → Selling, General & Admin: $87.55MExpenses → Research & Development: $12.00MExpenses → Other Expenses: $7.50MNet Loss → Expenses: $35.27MDevelopment Services → Revenue: $9.30MGross Profit$71.78MNet Loss$35.27MCost of Revenue$16.72MExpenses$107.05MSelling, General & Admin$87.55MResearch & Development$12.00MOther Expenses$7.50MRevenue$88.50MDiagnostic Tests$79.20MDevelopment Services$9.30M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BDSX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
88.50M71.32M49.09M38.21M54.51M
71.78M55.75M36.08M24.06M23.99M
-27.87M-34.50M-41.34M-50.59M-39.32M
-35.27M-42.93M-52.15M-65.45M-43.16M
-4.67-6.64-12.80-31.00-31.60
BDSX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
18.99M26.25M26.28M43.09M32.71M
87.48M97.24M99.10M92.91M76.10M
89.94M76.37M94.52M72.30M56.37M
72.85M61.98M60.69M31.85M10.01M
-2.46M20.88M4.58M20.61M19.73M
BDSX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-23.27M-48.65M-22.87M-44.97M-28.22M
-403.00K-3.44M-23.06M-3.53M-2.55M
16.42M52.05M29.13M58.88M1.26M
-403.00K-3.44M-23.06M-3.53M-2.55M
-7.26M-39.00K-16.80M10.38M-29.51M